StrokeDx Becomes NeuraNova, Marking a New Chapter in Portable Neurovascular Diagnostics

StrokeDx has officially rebranded as NeuraNova, a name that reflects its role as an emerging leader in non-invasive, portable neurovascular diagnostic technology.

Driven by the mission to deliver life-saving precision when every second counts, NeuraNova is committed to revolutionizing neurovascular diagnostics and ensuring rapid, reliable responses in critical moments. Its breakthrough technologies are designed to simplify the complexities of neurovascular assessment and provide clinicians with clear, actionable insights when they matter most.

NeuraNova is currently developing two innovative devices built on a shared core sensor technology:

• STEDI Scan — A portable, automated bioimpedance-based instrument designed for hospital settings to monitor patients at risk of brain fluid-volume changes. STEDI non-invasively measures the distribution of fluid in the head and provides clinicians with rapid, objective information at the bedside.

• FLASH Device — Leveraging the same advanced sensor technology, FLASH offers a handheld, compact design ideal for in-field or event-site diagnostics, expanding access to timely neurovascular assessment beyond traditional care environments.

“Our new identity, NeuraNova, represents the next chapter in our journey,” said Bob Colloton, CEO of NeuraNova. “It reflects our commitment to advancing a portfolio of portable, sensor-driven technologies that improve access to timely, actionable physiologic information across diverse care settings.”

For more information, please contact:
Bob Colloton
CEO
bob@neuranova.co
408.892.4411

The devices described are currently under development and have not been cleared or approved by the U.S. Food and Drug Administration. They are not available for sale or clinical use.